Mira Pharmaceuticals (MIRA) Cash from Operations (2022 - 2025)

Mira Pharmaceuticals has disclosed Cash from Operations across 4 years of filings, most recently posting 1173368.0 for Q4 2025.

• Cash from Operations for Q4 2025 came in at 1173368.0, up 34.99% year-over-year; the trailing twelve-month figure through Dec 2025 was 4700000.0 (up 15.48% YoY), and the FY2025 annual result was 4700000.0, up 15.48% from the prior year.
• Cash from Operations came in at 1173368.0 for Q4 2025 at Mira Pharmaceuticals, down from 1126632.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 660813.0 in Q2 2023 to a low of 1842111.0 in Q3 2024.
• The 4-year median for Cash from Operations is 1100969.0 (2023), against an average of 1220245.36.
• Across the five-year window, Cash from Operations plunged 74.4% in 2024 and jumped 38.84% in 2025, its largest moves.
• Mira Pharmaceuticals' Cash from Operations stood at 975436.0 in 2022, then retreated by 6.11% to 1035015.0 in 2023, then slumped by 74.4% to 1805030.0 in 2024, then soared by 34.99% to 1173368.0 in 2025.
• The last three Cash from Operations figures came in at 1173368.0 (Q4 2025), 1126632.0 (Q3 2025), and 800000.0 (Q2 2025), per Business Quant data.